Executive & Team Members
Nocturol, Inc. utilizes world class consultants and partners as needed to work quickly and efficiently towards our goals.
Lokesh Thadhani
V.P. Worldwide Partnerships
Go-To-Market Strategy, International Business, Partnerships & Alliance Management, Licensing & Regulatory Affairs
David Shantz
Chief Marketing Officer
Senior roles in multiple medical products and devices; CoAlign (acquired by Styker), Kalera, ZKROrtho, Introvein, plus 6 technology-based, venture-backed start-ups.
Dr. Michael Myers
Dr. Michael Myers is CoFounder, Chief Executive Officer and Director of Quoin Pharmaceuticals
DISCLAIMER
PLEASE NOTE THAT NOCTUROL HAS NOT BEEN APPROVED BY THE FDA OR EMA OR ANY OTHER REGULATORY AUTHORITY. NOCTUROL IS CURRENTLY UNDERGOING A PHASE 2 CLINICAL TRIAL.